Sunday is International Women’s Day and several of this week’s events highlight the accomplishments of women in entertainment. We’ve also got a stage play on the life of Galileo, several classical ...

Not all street-level heroes stay grounded.

As consumers continue to ponder the return on investment of a traditional four-year college education, Arkansas two-year ...

Chief Executive Officer Joe Payne told investors at the Leerink Partners Global Healthcare Conference that the company has ...

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is ...

Cathie Wood’s ARK ETF published their daily trades for Wednesday, March 18th, 2026, highlighting significant moves in the biotech sector. The most notable transaction was the sa ...

In the preceding three months, 4 analysts have released ratings for Arcturus Therapeutics (NASDAQ:ARCT), presenting a wide array of perspectives from bullish to bearish. In the table below, you'll ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Arcturus Therapeutics (ARCT) on Tuesday reported a loss of $29.1 million in its fourth quarter. The San Diego-based company said it had a loss of $1.03 per share. The ...

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and ...

Management is transitioning the ARCT-032 cystic fibrosis program into a 12-week Phase II study to better capture clinical healing and efficacy signals beyond the initial 'onboarding' phase. The ...

About Arcturus Therapeutics Holdings Inc. Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious ...